Researchers from the Duke University have deciphered the way in which stem cells present in the malignant brain cancer glioma could most aptly defend against radiation therapy. By employing a drug for blocking a certain signalling pathway in such cancer stem cells, they could annihilate greater numbers of glioma cells with radiation in a lab trial.Read original story